| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0042 | 0.9 |